The payers: how US insurers became the toll road

An insurer's business comes down to one number: of every dollar it collects in premiums, how much does it pay back out as care? That figure — the medical-loss ratio — is the engine of the whole model, and it creates an incentive that many people outside the US find startling: a company that profits, in part, by paying out less. Understanding that incentive is the key to understanding health insurance stocks, and why this link draws more political heat than any other.

Where this sits in the chain

The Payers are the funding link. They collect premiums from employers and individuals, then pay the providers and middlemen who deliver and distribute care. Crucially, the biggest payers have expanded into those neighbouring links — owning clinics, pharmacies, and the pharmacy middlemen — so the boundaries blur. For the full map, see The System.

What this link is — and why non-US readers should read it as "how the companies earn," not "how healthcare works"

This is the most American link in the chain, so the non-US lens matters most here:

• Premium — the regular payment (usually from an employer or the government on a person's behalf) that buys insurance coverage.
• Medical-loss ratio (MLR) — the share of premiums paid back out as medical care. US rules set a floor on this, so insurers compete and profit at the margins around it.
• Managed care — the model where the insurer actively manages which care is covered, through networks and approvals.
• Medicare Advantage — privately run versions of the government's Medicare programme for older Americans, paid for by the government but operated by these companies. It is a central growth engine for the link.

If you live in a country with a national health system, much of this simply has no local equivalent. Read it as a study of how these businesses make money, not as a description of care everywhere.

The companies

UnitedHealth Group (UNH)

What they do: The giant that both insures patients and delivers their care. UnitedHealthcare is the insurance arm; Optum is a sprawling business spanning care delivery, data, and pharmacy. The numbers: [refresh: latest quarter revenue; medical-loss ratio; Medicare Advantage membership]. The edge: unmatched scale plus vertical integration — it can capture margin across insurance, care, and pharmacy at once. The risk: that same integration draws regulatory and antitrust scrutiny; Medicare Advantage faces rate and rising-utilisation pressure; and the company has absorbed intense political and public criticism over coverage denials. It is, more than any peer, a lightning rod.

Elevance Health (ELV)

What they do: a major insurer operating Blue Cross Blue Shield plans across many states (formerly Anthem). The numbers: [refresh: latest quarter; membership trends]. The edge: entrenched Blue-branded scale in its regions. The risk: exposure to Medicaid — as eligibility was re-checked after the pandemic, membership and rates came under pressure.

Cigna (CI)

What they do: an employer-focused insurer whose Evernorth arm includes one of the largest pharmacy middlemen (a direct bridge to The Middlemen). The numbers: [refresh: latest quarter; Evernorth contribution]. The edge: a large, profitable pharmacy-services business alongside employer health plans. The risk: that pharmacy-middleman business is squarely in regulators' sights, creating policy risk.

Humana (HUM)

What they do: a near pure-play on Medicare Advantage — insurance for older Americans. The numbers: [refresh: latest quarter; MA membership; medical cost trend]. The edge: focus and expertise in the fast-growing Medicare Advantage market. The risk: that focus cuts both ways — concentrated exposure to exactly the place where government rates and patient-cost trends are squeezing hardest.

Context, not profiles. Centene and Molina focus on government-funded Medicaid plans; both are useful reference points. For non-US readers, the contrast with single-payer systems (such as the UK's NHS) is the clearest way to see how unusual this link is.

The bull and bear case

The bull case: entrenched scale, valuable data, and vertical integration create wide moats, while the ageing population steadily expands the Medicare market these companies serve.

The bear case: the link is a permanent political target — over denials, pricing, and the sheer profitability of sitting between patients and care. Medical costs can rise faster than premiums in any given year, squeezing the MLR, and regulators could force the integrated giants to unwind parts of their model.

What feeds it, what it feeds

The Payers collect from employers and government and pay the providers upstream. Between their cheque and the patient's medicine sits a hidden layer they increasingly own — The Middlemen, the next link. The pricing politics and demographic forces that move every payer are gathered in The Forces. Back to the map: The System.

This article is for information only and is not investment advice or a recommendation to buy or sell any security. [Publication] is not a licensed financial adviser. Figures are accurate as of June 2026 and will change. Markets carry risk, including loss of capital. Rules, taxes, and available products differ by country — do your own research and consider a locally regulated professional.